Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4785628
Max Phase: Preclinical
Molecular Formula: C49H95N25O12
Molecular Weight: 1226.46
Molecule Type: Unknown
Associated Items:
ID: ALA4785628
Max Phase: Preclinical
Molecular Formula: C49H95N25O12
Molecular Weight: 1226.46
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(N)=O)[C@@H](C)O
Standard InChI: InChI=1S/C49H95N25O12/c1-25(66-39(80)28(67-27(3)76)14-8-20-62-46(54)55)38(79)68-31(15-9-21-63-47(56)57)43(84)73-34(24-35(52)77)45(86)72-32(16-10-22-64-48(58)59)42(83)70-29(12-4-6-18-50)40(81)69-30(13-5-7-19-51)41(82)71-33(17-11-23-65-49(60)61)44(85)74-36(26(2)75)37(53)78/h25-26,28-34,36,75H,4-24,50-51H2,1-3H3,(H2,52,77)(H2,53,78)(H,66,80)(H,67,76)(H,68,79)(H,69,81)(H,70,83)(H,71,82)(H,72,86)(H,73,84)(H,74,85)(H4,54,55,62)(H4,56,57,63)(H4,58,59,64)(H4,60,61,65)/t25-,26+,28-,29-,30-,31-,32-,33-,34-,36-/m0/s1
Standard InChI Key: IJIHRTZHINQMRH-UXTPEBOCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1226.46 | Molecular Weight (Monoisotopic): 1225.7592 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Lewandowska-Goch MA,Kwiatkowska A,Łepek T,Ly K,Navals P,Gagnon H,Dory YL,Prahl A,Day R. (2021) Design and Structure-Activity Relationship of a Potent Furin Inhibitor Derived from Influenza Hemagglutinin., 12 (3): [PMID:33738063] [10.1021/acsmedchemlett.0c00386] |
Source(1):